NCT06463457: An ongoing trial by Atish Choudhury, MD
This trial is ongoing. It must report results 4 years, 3 months from now.
Full data
Full entry on ClinicalTrials.gov | NCT06463457 |
---|---|
Title | Comeback From Long coursE ADT With RElugolix and Darolutamide in Hormone-sensitive Prostate Cancer (CLEARED) |
Results Status | Ongoing |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | Dec. 13, 2024 |
Completion date | Nov. 30, 2028 |
Required reporting date | Nov. 30, 2029, midnight |
Actual reporting date | None |
Date last checked at ClinicalTrials.gov | Aug. 12, 2025 |
Days late | None |